Pacific Biosciences Of California PACB
NASDAQ PACB
$2.54 +0.03 (+1.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pacific Biosciences Of California (PACB) Cash & Equivalents (2010 - 2026)

Updated

Pacific Biosciences Of California's Cash & Equivalents came in at $61 million for Q2 2026, up 11.3% from $54.8 million a year earlier and up 8.4% from the prior quarter.

Analysis

Pacific Biosciences Of California (PACB) Cash & Equivalents (2010 - 2026) Analysis & Trends

At the end of FY2025, Pacific Biosciences Of California's Cash & Equivalents was $63.71 million, up 15.1% from FY2024.

  • Cash & Equivalents carries a five-year compound annual growth rate of -4.8% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $55.37 million in FY2024 (-69.2%), $179.91 million in FY2023 (-44.7%), $325.09 million in FY2022 (-29.4%) and $460.73 million in FY2021 (+464.5%).
  • The five-year range for quarterly Cash & Equivalents is $54.8 million (Q2 2025) to $460.73 million (Q4 2021).
  • Year-over-year, Cash & Equivalents increased in two of the last eight quarters, with an average decline of 27.8%.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2021 (growth of 516.3%), and the weakest in Q3 2024 (a decline of 79.8%).
  • Business Quant data shows PACB's Cash & Equivalents at $56.27 million (Q1 2026), $63.71 million (Q4 2025) and $56.47 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Thermo Fisher Scientific 241.25 Bn 220.40 Bn 4.88 Bn 4.06 Bn
2 Abbott Laboratories 167.33 Bn 138.41 Bn 7.27 Bn 5.10 Bn
3 Danaher 148.83 Bn 132.65 Bn 3.61 Bn 4.35 Bn
4 Intuitive Surgical 142.00 Bn 121.55 Bn 1.96 Bn 2.76 Bn
5 Medtronic 110.70 Bn 76.57 Bn 6.34 Bn 1.69 Bn
6 Stryker 104.72 Bn 90.84 Bn 4.50 Bn 3.39 Bn
7 Boston Scientific 62.66 Bn 57.67 Bn 3.85 Bn 539.00 Mn
8 Edwards Lifesciences 49.13 Bn 33.24 Bn 1.35 Bn 2.91 Bn
9 Becton Dickinson 48.51 Bn 45.66 Bn 2.32 Bn 708.00 Mn
10 Pacific Biosciences Of California 780.13 Mn -310.86 Mn 12.64 Mn 61.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 61.00 Mn
Mar 31, 2026 56.27 Mn
Dec 31, 2025 63.71 Mn
Sep 30, 2025 56.47 Mn
Jun 30, 2025 54.80 Mn
Mar 31, 2025 58.51 Mn
Dec 31, 2024 55.37 Mn
Sep 30, 2024 77.98 Mn
Jun 30, 2024 99.53 Mn
Mar 31, 2024 76.65 Mn
Dec 31, 2023 179.91 Mn
Sep 30, 2023 385.65 Mn
Jun 30, 2023 209.29 Mn
Mar 31, 2023 353.83 Mn
Dec 31, 2022 325.09 Mn
Sep 30, 2022 304.43 Mn
Jun 30, 2022 310.45 Mn
Mar 31, 2022 428.57 Mn
Dec 31, 2021 460.73 Mn
Sep 30, 2021 425.39 Mn
API Access

Pacific Biosciences Of California Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PACB&period=max&api_key=YOUR_API_KEY